A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson's disease model.
Zeng S, Zhang S, Gui X, Li D, Lv S, Dong H, Xu Q, Wu J, Ren H, Zhao Q, Long H, Yu Y, Hou S, Le W, Fan M, Liu D, Li D, Liu C.
Zeng S, et al. Among authors: zhao q.
Cell Rep. 2026 Jan 22;45(2):116897. doi: 10.1016/j.celrep.2025.116897. Online ahead of print.
Cell Rep. 2026.
PMID: 41575853